Treatment of thrombotic Antiphospholipid Syndrome (APS)

Info about APS can be found here: reconnet.ern-n...
Speaker
Prof. Maria Tektonidou is Professor of Rheumatology, Head of Rheumatology Unit, and Head of the National Center of Expertise for rCTDS, the First Department of Propaedeutic Internal Medicine, University of Athens, Greece. Prof. Tektonidou is Executive board member of the Joint Academic Rheumatology program, University of Athens, “EULAR Centre of Excellence” (2021-2026). Prof. Tektonidou is leading the “EULAR APS study group” (2019-present) and she convened the “EULAR Recommendations for the management of APS in adults” (2019), the “EULAR recommendations for the cardiovascular management of RMDs including SLE and APS” (2022), and she is currently convening the "Development and Validation of a EULAR disease activity score in APS" project. In addition, Prof. Tektonidouis steering committee member of the “ACR/EULAR Classification Criteria for APS”. Prof. Tektonidou is disease coordinator of the ERN ReCONNET APS group, a steering committee member of the APS ACTION, and executive committee member of SLEuro.